I thought I would jump in on this topic of loss of smell
Zicam over the counter medicine that is still being sold
No. 09–1156. Argued January 10, 2011—Decided March 22, 2011
Respondents filed this securities fraud class action, alleging that petitioners (hereinafter Matrixx) violated §10(b) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b–5 by failing to disclose reports of a possible link between Matrixx’s leading product, Zicam Cold Remedy, and loss of smell (anosmia),
I thought I would jump in on this topic of loss of smell Zicam over the counter medicine that is still being sold
No. 09–1156. Argued January 10, 2011—Decided March 22, 2011
Respondents filed this securities fraud class action, alleging that petitioners (hereinafter Matrixx) violated §10(b) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b–5 by failing to disclose reports of a possible link between Matrixx’s leading product, Zicam Cold Remedy, and loss of smell (anosmia),
https://supreme.justia.com/cases/federal/us/563/27/